Zusammenfassung
Vaskuläre Erkrankungen spielen bei der heute vorherrschenden Altersstruktur der Bevölkerung in der westlichen Welt eine dominierende Rolle, sowohl was die Morbidität als auch die Mortalität anbelangt. Dabei sind es — vielleicht mit Ausnahme von traumatischen Ereignissen mit akutem Blutverlust — nicht die Gefäßläsionen per se, die das klinische Bild bei manifesten vaskulären Erkrankungen beherrschen, vielmehr dominieren die daraus resultierenden Organbeeinträchtigungen mit allen ihren Folgeerscheinungen. Es sind also in erster Linie Störungen in der nutritiven Mikrozirkulation, die die klinische Symptomatik bedingen. Die therapeutischen Interventionsversuche der jüngeren Zeit zielen folgerichtig darauf ab, das Fließ verhalten des Blutes im Mikrozirkulationsbereich positiv zu beeinflussen, wobei den intrinsischen Fließeigenschaften ein besonderer Stellenwert beigemessen wird (1, 2). So hat es nicht an Ansätzen gefehlt, sowohl durch gezielte Verbesserung der Theologischen Eigenschaften von Erythrozyten (3), Thrombozyten (4) oder Plasmaproteinen (5) als auch unspezifisch durch unterschiedliche Hämodilutionsverfahren (6,7) die Fließeigenschaften des Blutes speziell im Bereich der nutritiven Mikrozirkulation zu verbessern.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Stuart J, Kenny MW (1980) Blood rheology. J Clin Pathol 33: 417–429
Chien S (1983) Hemorheology — normal physiology and pathological changes in blood viscosity and blood flow. In: Spittell JA (ed) Pharmacological Approach to the Treatment of Limb Ischemia. College of Physicians, Philadelphia
Schmid-Schönbein H (1981) Blood rheology and physiology of microcirculation. In: Manrique RV, Müller R (eds) Disorders of Blood Flow — New Therapeutic Aspects. Excerpta Medica, Amsterdam
Born GVR (1983) Hemorheological influences on platelet thrombogenesis. Eur Neurol 22 (Suppl I): 30–34
Ehrly AM (1976) Therapy of occlusive arterial diseases with ancrod. Artery 2: 98–108
Rieger H, Köhler M, Schoop W (1979) Hemodilution (HD) in patients with ischemic skin ulcers. Klin Wochenschr 57:1153–1161
Gottstein U (1981) Einfluß der Hämodilution sowie der Blutviskosität auf die zerebrale Zirkulation mit Konsequenzen für die Therapie. Arzn-Forsch/Drug Res 31: 2028–2032
Ames A, Wright RL, Kowada M, Thurston JM, Majno G (1968) Cerebral ischemia II — the no reflow phenomenon. Am J Pathol 52: 437–453
Schmid-Schönbein GW, Skalak R (1986) Leukocyte rheology. In: Skalak R, Chien S (eds) Handbook of Bioengineering. McGraw-Hill Publishers, New York
Lucchesi BR (1986) Leukocytes and ischemia-induced myocardial injury. Ann Rev Pharmacol Toxicol 26: 201–224
Engler RL, Schmid-Schönbein GW, Pavelec RS (1983) Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 111: 98–111
Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA (1987) Leukocytes and the risk of ischemic diseases. JAMA 257: 2318–2324
Schönharting MM, Labs KH (1988) Pathophysiologische Auswirkungen von Leukozyten-Endothel-Interaktionen auf die Mikrozirkulation. CorVas 2: 211–220
Harlan JM (1985) Leukocyte-endothelial interactions. Blood 65: 513–525
Vedder NB, Winn RK, Rice CL, Chi EY, Arfors K-E, Harlan JM (1988) Amonoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD 18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest 81: 939–944
Williams TJ, Rampart M, Nourshargh S, Hellewell PG, Brain SD, Jose PJ (1987) Interaction of poly-morphonuclear leukocytes and endothelial cells — functional consequences.Thromb Haemostas 58: 326/A 1186
Nees S (1987) Neuere Erkenntnisse zur Physiologie und Pathophysiologie des Gefäßendothels, vor allem im Rahmen der Atherogenese. Internist 28: 699–710
Thilo-Körner DGS, Heinrich D, Lasch HG (1983) Endothelial cell control functions in blood coagulation. In: Thilo-Körner DGS, Freshney RI (eds) The Endothelial Cell — a Pluripotent Control Cell of the Vessel Wall. Karger, Basel
Nawroth PP, Steimu DM (1986) Endothelial cells as active participants in procoagulant reactions. In: Gimbrone MA jr (ed) Vascular Endothelium in Hemostasis and Thrombosis. Churchill Livingstone, Edinburgh London New York
Loskutoff DJ (1986) The fibrinolytic system of cultured endothelial cells — insights into the role of endothelium in thrombolysis. In: Gimbrone MA jr (ed) Vascular Endothelium in Hemostasis and Thrombosis. Churchill Livingstone, Edinburgh London New York
DiCorleto PE (1984) Cultured endothelial cells produce multiple growth factors for connective tissue cells. Exp Cell Res 153:167–172
Busse R, Trogisch G, Bassenge E (1985) The role of endothelium in the control of vascular tone. Basic Res Cardiol 80: 475–490
Davies PF (1984) Quantitative aspects of endocytosis in cultured endothelial cells. In: Jaffe EA (ed) Biology of Endothelial Cells. Martinus Nijhoff Publ, Boston
Bar RS (1982) Interactions of insulin and insulin-like growth factors with endothelial cells. Ann NY Acad Sci 401:150–162
Henriksen T, Mahoney EM, Steinberg D (1982) Interactions of plasma lipoproteins with endothelial cells. Ann NY Acad Sci 401:102–116
Gimbrone MA jr (1986) Vascular endothelium — nature’s blood container. In: Gimbrone MA jr (ed) Vascular Endothelium in Hemostasis and Thrombosis. Churchill Livingstone, Edinburgh London New York
Busch C, Cancilla PA, DeBault LE, Goldsmith JC, Owen WG (1982) Use of endothelium cultured on microcarriers as a model for the microcirculation. Lab Invest 47:498–504
Roitt IM (1984) Leitfaden der Immunologie. Steinkopff, Darmstadt
Kaufmann SHE (1987) Lymphokine, Interleukine, Zytokine — Funktion und Wirkungsmechanismus. J Am Coll Cardiol 7: 681–687
Bonavida B, Gifford GE, Kirchner H, Old JL (1988) Tumor Necrosis Factor/Cachectin and Related Cytokines. Karger, Basel
Dinarello CA, Mier JW (1987) Lymphokines. New Engl J Med 8: 940–945
Bevilacqua MP, Wheeler ME, Pober JS, Fiers W, Mendrick DL, Cotran RS, Gimbrone MA jr (1987) Endothelial-dependent mechanisms of leukocyte adhesion: regulation by IL-1 and TNF. In: Movat HZ (ed) Leukocyte Emigration and its Sequelae. Karger, Basel
Larrick JW, Graham D, Toy K, Lin LS, Senyk G, Fendly BM (1987) Recombinant tumor necrosis factor causes activation of human granulocytes. Blood 69: 640–644
Gamble JR, Harlan JM, Klebanoff SJ, Vades MA (1985) Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 82: 8667–8671
Pober JS, Gimbrone MA jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA (1986) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137:1893–1896
Nawroth PP, Stern DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740–745
Aggarwal BB (1987) Tumor necrosis factors — their structure and pleiotropic biological effects. Drugs Fut 12: 891–898
Old LJ (1988) Antitumor activity of microbial products and tumor necrosis factor. In: Bonavida B, Gifford GE, Kirchner H, Old LJ (eds) Tumor Necrosis Factor/Cachectin and Related Cytokines. Karger, Basel
Feinman R, Henriksen-DiStefano D, Tsujimoto M, Vilcek J (1987) Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J Immun 138: 635–640
Beller DJ, Farr AG, Unanue ER (1978) Regulation of lymphocyte proliferation and differentiation by macrophages. Fed Proc 37: 91–96
Maizel AL, Lachman LB (1984) Biology of disease — control of human lymphocyte proliferation by soluble factors. Lab Invest 50: 369–377
Mizel SB (1982) The interleukins — regulation of lymphocyte differentiation, proliferation, and functional activation. In: Mihich E (ed) Biological Responses in Cancer. Plenum Press, New York
Freudenberg M, Keppler D, Galanos C (1986) Requirement for lipopolysaccharide-responsive macrophages in D-galactosamine-induced sensitization to endotoxin. Infect Immun 51: 891–895
Chenoweth DE, Goodman MG (1983) The C5a receptor of neutrophils and macrophages. Agents Actions 12: 252–263
Trinchieri G, Perussia B (1985) Immune interferon — a pleiotropic lymphokine with multiple effects. Immunol Today 6: 131–141
Hogg J (1987) Neutrophil kinetics and lung injury. Physiol Rev 67: 1249–1295
Libby P, Ordovas JM, Auger KR, Robbins AH, Birinyi LK, Dinarello CA (1986) Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol 124: 179–185
Bussolino F, Breviario F, Tetta C, Aglietta M, Sanavio F, Mantovani A, Dejana E (1986) Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. Pharmacol Res Commun 18: 133–137
Müller-Berghaus G (1987) Septicemia and the vussel wall. In: Verstraete M et al (eds) Thrombosis and Haemostasis. Leuven University Press, Leuven
Grega GI (1986) Contractile elements of endothelial cells as potential targets for drug action. Trends Pharmacol 7: 452–457
Cotran RS, Pober JS (1988) Endothelial activation. Its role in inflammatory and immune reactions. In: Simionescu N, Simionescu M (eds) Endothelial Cell Biology in Health and Disease. Plenum Press, New York
Montesano R, Mossaz A, Ryser JE, Orci L, Vassalli P (1984) Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix. J Cell Biol 99:1706–1715
Gimbrone MA jr, Bevilacqua MP, Wheeler ME (1987) Endothelial-dependent mechanisms of leukocyte adhesion. Thromb Haemostas 58: 325/A1184
Sanchez-Madrid F, Nagy J, Robbins E, Simon P, Springer TA (1983) A human leukocyte differentiation antigen family with distinct α-subunits and a common β-subunit: the lymphocyte function-associated antigen (LFA-1), the 3bi complement receptor (OKM1/Mac-1), and the p 150,95 molecule. J Exp Med 158:1785–1803
Sturk A, Schaap MCL, ten Cate JW, Heymans HSA, Schutgens RBH, Przyrembel H, Borst P (1987) Platelet-activating factor: mediator of the third pathway of platelet aggregation? J Clin Invest 79:344–350
Bagge U, Braide M (1985) Der Einfluß der Leukozyten auf die Mikrozirkulation im Schock. In: Meß-mer K, Hammersen F (Hrsg) Entzündung und Rheologie der Leukozyten. Karger, Basel
Stossel TP (1974) Phagocytosis. New Engl J Med 290: 717–723, 774-780, 833-839
Henson PM (1981) Neutrophil secretion: Mechanisms and consequences in inflammation. In: Venge P, Lindbom A (eds) The Inflammatory Process. An Introduction to the Study of Cellular and Humoral Mechanisms. Almovist & Wiksell, Stockholm
Henriksen T, Mahoney EM, Steinberg D (1981) Enhanced macrophage degradation of low-density lipoprotein previously incubated with cultured endothelial cells. Proc Natl Acad Sci USA 78: 6499–6503
Mazzone T, Jensen M, Chait A (1983) Human arterial-wall cells secrete factors that are chemotactic for monocytes. Proc Natl Acad Sei USA 80: 5094–5097
Hirschberg H, Braathen LR, Thorsby E (1982) Antigen presentation by vascular endothelial cells and epidermal Langerhans cells — the role of HLA-DR. Immunol Rev 66: 57–77
Collins T, Korman AI, Wake CT, Boss IM, Kappes DI, Fiers N, Ault KA, Gimbrone MA, Strominger IL, Pober JS (1984) Immune interferon activates multiple class-II-major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 81: 4917–4921
Wagner CR, Vetto RM, Burger DR (1984) The mechanism of antigen presentation by endothelial cells. Immunobiology 168: 453–469
Joris I, Billingham ME, Majno G (1984) Human coronary arteries — an ultrastructural search for the early changes of atherosclerosis. Fed Proc 43: 710–716
Ulutin ON (1986) Atherosclerosis and hemostasis — a review. Semin Thromb Hemostas 12:156–174
Phelps P, McCarty DJ (1966) Crystal-induced inflammation in canine joints. II. Importance of PMN. J Exp Med 124:115–126
Dayer JM, Bréard J, Chess L, Krane SM (1979) Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. J Clin Invest 64: 1386–1392
Cochrane CG, Unanu ER, Dixon FJ (1965) A role of PMN and complement in nephrotoxic nephritis. J Exp Med 122: 99–116
Eisenbarth GS (1986) Type I diabetes mellitus, a chronic autoimmune disease. New Engl J Med 314: 1360–1368
Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J (1987) Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J Immunol 139:4077–4082
Benveniste J, Coëffier E (1985) Die Wechselbeziehungen zwischen Leuko-und Thrombozyten während der Entzündung. In: Meßmer K, Hammersen F (Hrsg) Entzündung und Rheologie der Leukozyten. Karger, Basel
Gaethgens P, Ley K, Pries AR, Müller R (1985) Mutual interaction between leukocytes and microvascular blood flow. Progr Appl Microcirc 7:15–28
Smedegård G (1985) Die Mediatoren der entzündlich gesteigerten Gefäßpermeabilität. In: Meßmer K, Hammersen F (Hrsg) Entzündung und Rheologie der Leukozyten. Karger, Basel
Dahlen S, Bjork J, Hedqvist P, Arfors K, Hammarstrom S, Lindgren J, Samuelsson B (1981) Leuko-trienes promote plasma leakage and leukocyte adhesion in postcapillary venules. Proc Natl Acad Sci USA 78: 3887–3896
Humphrey DM, McManus LM, Hanahan DJ, Pinckard RN (1984) Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. Lab Invest 50: 16–25
Nees S (1989) Zelluläre und humorale Reaktionen und Interaktionen im Bereich der Gefäßwand während eines Kreislaufschocks. In: Peter K (Hrsg) Anästhesiologie und Intensivmedizin. Springer, Berlin
Stevens JH, Raffln TA (1984) Adult respiratory distress syndrome. Postgrad Med 60: 505–513
Goris RJA (1987) The adult respiratory distress syndrome and multiple-organ failure. Intens Care 1: 1–7
Majno G, Joris I, Zand T (1985) Arteriosclerosis — new horizons. Hum Pathol 16: 3–5
Lee KT (1985) Atherosclerosis, Vol 454, Ann NY Acad Sci, New York
Coleridge-Smith PD, Thomas P, Scurr JH, Dormandy JA (1988) Causes of venous ulceration — a new hypothesis. Brit Med J 296:1726–1727
Nash GB, Thomas PRS, Dormandy JA (1988) Abnormal flow properties of white blood cells in patients with severe ischaemia of the leg. Brit Med J 296:1699–1701
Vermes I, Strik F (1988) Altered leukocyte rheology in patients with chronic cerebrovascular disease. Stroke 19: 631–633
Barckow D, Schirop T(1987) Klinik und Prognose des akuten Lungenversagens. Atemw Lungenkrkh 13: 527–533
Täte RM, Repine JE (1983) Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 128: 3–15
Hammerschmidt DE, Harris PD, Wayland JH (1981) Complement-induced granulocyte aggregation in vivo. Am J Pathol 102:146–150
Nuytinck JKS, Goris RJA, Redl H, Schlag G, van Munster PJJ (1986) Posttraumatic complications and inflammatory mediators. Arch Surg 121: 886–890
Barroso-Aranda J, Schmid-Schönbein GW (1989) Transformation of neutrophils as measured by NBT-reduction as indicator of irreversibility in hemorrhagic shock. Am J Physiol, im Druck
Blombery PA (1987) Intermittent claudication — an update on management. Drugs 34: 404–410
Heinrich F (1986) Akutes Cor pulmonale — Diagnostik und Therapie in der Klinik. Therapiewoche 36: 3233–3241
Demling RH (1986) Cardiopulmonary dysfunction from sepsis — diagnosis and treatment. In: Proctor RA (ed) Handbook of Endotoxin Vol 4. Elsevier, Amsterdam New York Oxford
Tracey KJ, Fong Y, Hesse DG, Manogue KR, Annette TL, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662–664
Weigelt JA, Norcross JF, Borman KR, Snyder WH (1985) Early steroid therapy for respiratory failure. Arch Surg 120: 536–540
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Schönharting, M.M. (1990). Die Rolle von mononukleären Zellen und deren Zytokinen in der Pathophysiologie vaskulärer Erkrankungen. In: Kark, B., Werner, H. (eds) Herz- und Kreislauferkrankungen im Alter. Steinkopff. https://doi.org/10.1007/978-3-642-85384-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-85384-5_1
Publisher Name: Steinkopff
Print ISBN: 978-3-642-85385-2
Online ISBN: 978-3-642-85384-5
eBook Packages: Springer Book Archive